1.Bioactive Metobolites from Gliocladium
Jin-Yan DONG ; Ru LI ; Ke-Qin ZHANG ;
Microbiology 1992;0(02):-
From the perspective of compound type,the bioactive metobolites from Gliocladium are reviewed,and the research advancement in future are proposed.
2.Application of Diagnosis Related Groups evaluation index in performance management system of hospitals
Liqiong MIAO ; Desheng SHAN ; Jin CHEN ; Yu YANG ; Jiang KE ; Hongyuan ZHU ; Li LI ; Weihua SUI ; Xiaocui LI ; Qin YANG
Chinese Journal of Hospital Administration 2015;(9):693-696
Objective To explore the use of Diagnosis Related Groups(DRGs)evaluation index in performance management system of hospitals.Methods The performance evaluation system was built based on medical business volume index,efficiency indicators,cost control indexes,drug control indexes, medical quality and medical safety indexes,by means of extracting the home page of hospital discharge records from 2009 to 2013 and grouping automatically with the“BJ-DRGs”group-maker.Results The operation evaluation indexes of the hospital have seen great progress since advent of the DRGs evaluation indexes.Conclusion Introduction of DRGs has scored great success in the performance appraisal system of the hospital.
3.Distribution, combination, and evolution of syndromic etiologies of erectile dysfunction.
Jian-Guo XUE ; Qian FAN ; Yu-Chun ZHOU ; Ke-Qin NING ; Jin-Song WANG ; Ting-Song BIAN
National Journal of Andrology 2014;20(9):830-833
OBJECTIVETo explore the distribution, combination and evolution of various syndromic etiologies of erectile dysfunction (ED) based on the syndrome etiology theory.
METHODSUsing the ED Syndromic Etiology Scale, we collected the clinical data on the Chinese medicine diagnoses of 297 cases of ED, extracted the core syndromic etiologies by analysis of principal components and factors, and analyzed the patterns of distribution, combination, and evolution of ED syndromic etiologies according to the general information of the patients.
RESULTSThrough analysis of principal components and factors, 9 core syndromic etiologies were extracted, i. e. , liver constraint with qi stagnation, kidney yin deficiency, damp-heat, liver constraint transforming into liver-fire, blood stasis, kidney yang deficiency, heart-spleen paired deficiency, qi-yin paired deficiency, and phlegm-damp. Each of these syndrome etiologies exhibited its own specific distribution patterns. Of the total number of cases studied, 51.52% had 2 or 3 core syndromic etiologies and 36.03% had only one.
CONCLUSIONIn the early stage of ED, its syndromic etiologies are usually liver constraint with qi stagnation, kidney yin deficiency, damp-heat, liver constraint transforming into liver-fire, and blood stasis. With the natural progres- sion of the disease, its syndromic etiologies gradually evolve into kidney yang deficiency, heart-spleen paired deficiency, qi-yin paired deficiency, phlegm-damp, and blood stasis, and finally into yin-yang deficiency of the heart, spleen and kidneys, combined with phlegm-damp and blood stasis.
Adult ; Erectile Dysfunction ; diagnosis ; drug therapy ; etiology ; Humans ; Male ; Medicine, Chinese Traditional ; Middle Aged
4.Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety.
Aifang QIN ; Yan LI ; Hongrui SONG ; Xiaoguang CHEN ; Xiaofeng JIN ; Ke WANG ; Lijing ZHANG ; Lianchao HUO ; Zhiqiang FENG
Acta Pharmaceutica Sinica 2012;47(12):1623-9
A novel series of sorafenib analogs containing 2-picolinyl hydrazide moiety were designed and synthesized. In vitro, most of synthesized compounds have antiproliferation activity on MDA-MB-231, ACHN, HepG2, Mia-PaCa-2 and SW1990 cell lines tested by MTT assay. It is worth noting that the antitumor activities of compounds 2c, 2d and 2f are more potent than that of sorafenib on pancreatic cancer cells Mia-PaCa-2 and SW1990, and the activities of compounds 3f and 3g are 2-3 times than that of sorafenib on human hepatocellular carcinoma HepG2 cell line.
5.LASS2 interacts with V-ATPase and inhibits cell growth of hepatocellular carcinoma.
Ning TANG ; Jie JIN ; Yun DENG ; Rong-Hu KE ; Qiu-Jin SHEN ; Shao-Hua FAN ; Wen-Xin QIN
Acta Physiologica Sinica 2010;62(3):196-202
Homo sapiens longevity assurance homologue 2 (LASS2) is a novel gene isolated from a human liver cDNA library by our laboratory, and it is a human homologue of the yeast longevity assurance gene LAG1 (Saccharomyces cerevisiae longevity assurance gene). According to our previous results, LASS2 could interact with subunit c of vacuolar type H(+)-ATPase (V-ATPase), and the overexpression of LASS2 could inhibit the cell growth of a human hepatocellular carcinoma (HCC) cell line, SMMC-7721. In order to understand the role of the interaction between LASS2 and V-ATPase in HCC cell growth, we transiently transfected plasmid pCMV-HA2-LASS2 into HCCLM3, a HCC cell line without the significant expression of endogenous LASS2. The pH-sensitive fluorescence probes, BCECF and BCECF-AM, were used to measure the intracellular and extracellular H(+) concentrations of HCCLM3 cells respectively. The effect of LASS2 gene on apoptosis was evaluated with Annexin-V/FITC and propidium iodide (PI) by flow cytometry. Western blot was used to detect cytochrome c (Cyt c) in the cytosol and mitochondria, as well as pro-caspase-3 in cytosol. The results showed that the cell growth of LASS2-transfected HCCLM3 cells was significantly inhibited compared with that of the mock control. LASS2 transfection increased intracellular H(+) concentration of HCCLM3 cells, while decreased extracellular H(+) concentration. Moreover, LASS2 transfection significantly enhanced the apoptosis of HCCLM3 cells. In LASS2-transfected cells, the amounts of Cyt c increased in the cytosol, while decreased in the mitochondria. Meanwhile, the expression of pro-caspase-3 in the cytosolic extracts was decreased. These results implicate that LASS2 gene might increase intracellular H(+) of HCC cells via the interaction with V-ATPase, thereby inducing cell apoptosis through mitochondrial pathway.
Apoptosis
;
Carcinoma, Hepatocellular
;
pathology
;
Caspase 3
;
metabolism
;
Cell Line, Tumor
;
Cell Proliferation
;
Humans
;
Liver Neoplasms
;
pathology
;
Membrane Proteins
;
metabolism
;
RNA, Small Interfering
;
Sphingosine N-Acyltransferase
;
metabolism
;
Transfection
;
Tumor Suppressor Proteins
;
metabolism
;
Vacuolar Proton-Translocating ATPases
;
metabolism
6.A study on the regional parameters of triple screening model of Down syndrome in the second trimester in Jinhua City
Yuan-Qiao WU ; Qun-Fang JIANG ; Ke-Qin JIN ; Hui-Jie JIN ; Zhang-Fang CHEN ; Xiao-Chun LI
Journal of Preventive Medicine 2015;(3):249-253
Objective To explore the regional parameters of triple screening model of Down syndrome in the second trimester in Jinhua City.Methods A total of 20 232 second trimester pregnant women with single fetus (gestational age at 15 -20 +6 weeks)was enrolled,and their serum samples were determined by American Perkin Elmer company Auto DELFIA automatic time -resolved fluorescence immunoassay analyzer for Down syndrome screening with triple markers, namely AFP,free β-hCG and uE3 .The risks of Down syndrome were evaluated by Lifecycle 3.2 software.And the risks of Down syndrome were re -calculated by local statistical median equations.Pregnant women were suggested to receive amniotic fluid fetal karyotype analysis if the risk of Down syndrome were equal or above 1 /270.Results Local median marker levels were significantly higher than the software built -in median levels (P <0.01).Both true -positive detection rates (sensitivity)were 87.50%.The false positive rate of local median equations was 4.24%,while the built -in median equations was 4.74%.Conclusion There are significant differences on the race and region by using the LifeCycle 3.2 median equations.The local equations may lower the false positive rate.
7.Progress in the research of carbon nanotubes as drug carriers.
Jin-gang YU ; Ke-long HUANG ; Qiao-qin YANG ; Su-qin LIU ; Jin-chun TANG
Acta Pharmaceutica Sinica 2008;43(10):985-991
Research and development of new drug carriers are crucial to the research of drugs. Due to their unique hollow structure and nano-diameter, carbon nanotubes (CNTs) can be used as drug carriers. Functionalization of CNTs with peptides, proteins, nucleic acids or even drug molecules, the so obtained functionalized CNTs can be used as carriers to deliver bioactive molecules into cells without causing any toxicity. The research progress of CNTs as drug carriers in recent years is summarized, and the CNTs' cytotoxicity and their ability to penetrate cells are discussed, and the methods of functionalizing carbon nanotubes are also mentioned in the paper. Along with the advancement of CNTs in drug carriers system, the relationship between the way to functionalize CNTs and the so obtained modified CNTs' ability to penetrate into cells, including the effect of dimension, should be further studied. Preparation of functionalized CNTs with high solubility and low toxicity as drug carriers will be the main research areas in the near future.
Animals
;
Biocompatible Materials
;
Drug Carriers
;
chemistry
;
Drug Design
;
Genetic Vectors
;
Humans
;
Nanotubes, Carbon
;
chemistry
;
Solubility
9.Testis homotransplantation: a report of 12 cases.
Yong ZHANG ; Feng-Shuo JIN ; Qian-Sheng LI ; Hong-Zhen SUN ; Fang-Qiang ZHU ; Ke-Qin ZHANG
National Journal of Andrology 2008;14(3):248-250
OBJECTIVETo evaluate the effect of testis homotransplantation in the treatment of androgen deficiency and infertility.
METHODSWe retrospectively analyzed 12 cases of testis homotransplantation.
RESULTSSurgical success was achieved in 11 cases, all with a significantly increased level of serum testosterone, and markedly improved secondary sex characteristics and sexual function.
CONCLUSIONTestis homotransplantation is highly effective for the treatment of androgen deficiency in males, but has little effect on spermatogenesis.
Adolescent ; Adult ; Humans ; Living Donors ; Male ; Retrospective Studies ; Testis ; transplantation ; Testosterone ; blood ; deficiency ; Transplantation, Homologous ; Treatment Outcome
10.Qinghuachang Decoction Inhibited NF-kappaB Activation in LPS-induced Human Enterocytes.
Jin-tuan CHEN ; Xiao KE ; Xin ZHANG ; Wen-yi FANG ; Chun-bo YANG ; Jun PENG ; You-qin CHEN ; Thomas J SPEERRA
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(11):1356-1360
OBJECTIVETo explore anti-inflammation and mechanism of Qinghuachang Decoction (QD) by using LPS stimulated differentiated colon cancer Caco-2 cells (as an inflammation model of human enterocytes).
METHODSQD was prepared. Human colonic epithelial Caco-2 cells were cultured. Expressions of TNF-alpha and IL-8 were determined using ELISA. Expressions of inhibitory Kaba protein (IkappaB-alpha), phosphorylated inhibitory Kaba protein (p-lkappaB-alpha), nuclear transcription factor p50 (p50), and nuclear transcription factor ReIA (ReIA) protein were determined by Western blot.
RESULTSCompared with the negative control group (without LPS stimulation), LPS stimulated the release of IL-8 and TNF-alpha in Caco-2 cells (P < 0.05). QD treatment could reduce the secretion of TNF-alpha and IL-8 induced by LPS in a dose dependent manner (P < 0.05). QD at 0, 5, 10, and 50 microg/mL had no significant effect on Caco-2 cell survival rates (P > 0.05), with no statistical difference among various concentrations (P > 0.05). QD could significantly suppress nuclear factor-kappa B (NF-kappaB) phosphorylation stimulated by LPS. The expression of p-IKappaB-alpha was decreased with increasing concentrations of QD (P < 0.05). There was no obvious change in IKB-alphaB expressions (P > 0.05). Expressions of p50 and ReIA decreased with increasing concentrations of QD (P < 0.05). Both of them were in a dose dependent manner.
CONCLUSIONQD inhibited LPS mediated NF-kappaB activation, which might be one of its mechanisms for treating inflammatory bowel disease (IBD).
Caco-2 Cells ; Colon ; Drugs, Chinese Herbal ; pharmacology ; Enterocytes ; Humans ; I-kappa B Proteins ; metabolism ; Inflammation ; Interleukin-8 ; Lipopolysaccharides ; NF-KappaB Inhibitor alpha ; NF-kappa B ; metabolism ; Phosphorylation ; Tumor Necrosis Factor-alpha ; metabolism